| 注册
首页|期刊导航|解放军医学院学报|乳酸杆菌与双歧杆菌对高脂血症治疗的相关性研究

乳酸杆菌与双歧杆菌对高脂血症治疗的相关性研究

闫志辉 崔立红 王晓辉 贺星 李超 弓三东 罗哲 季梦辰

解放军医学院学报Issue(10):983-986,1010,5.
解放军医学院学报Issue(10):983-986,1010,5.DOI:10.3969/j.issn.2095-5227.2015.10.006

乳酸杆菌与双歧杆菌对高脂血症治疗的相关性研究

Correlation of Lactobacillus and Bifidobacterium treatment for hyperlipidemia

闫志辉 1崔立红 1王晓辉 1贺星 1李超 1弓三东 1罗哲 1季梦辰1

作者信息

  • 1. 海军总医院 消化内科,北京 100048
  • 折叠

摘要

Abstract

Objective To investigate the correlation between clinical outcomes in patients with hyperlipidemia and the distribution of Lactobacillus and Bifidobacterium. Methods From March 2012 to June 2014, 120 cases with hyperlipidemia (85 males, 35 females, average age of (48.1±11.6) years) in our hospital were randomly divided into four groups, and they were provided with one-month treatment. Group A were treated with low fat diet + exercise; group B were treated with lipid-lowering drug therapy;group C were treated with intestinal flora regulator treatment; group D were treated with lipid-lowering drugs + modulators. The serum lipids and intestinal flora detections were given in all patients separately before admission, 1 month after treatment, and 3 months after treatment. The lipid levels of patients in four groups, the changes of intestinal microflora and the blood lipid sustainment after treatment in different periods were analyzed and compared. Results The total cholesterol (TC) of group C before treatment, 1 month and 3 months after treatment was (6.69±1.29) mmol/L, (6.18±1.04) mmol/L and (6.78±1.14) mmol/L, triglyceride (TG) was (1.91±0.32) mmol/L, (1.87±0.46) mmol/L, (1.93±0.28) mmol/L; high density lipoprotein cholesterol (HDL-C) was (0.91±0.35) mmol/L, (0.97±0.33) mmol/L, (0.97±0.36) mmol/L; while TC in group D was (6.79±1.39) mmol/L, (4.11±1.07) mmol/L, (4.27±1.03) mmol/L, TG: (1.90±0.55) mmol/L, (1.36±0.41) mmol/L, (1.39±0.29) mmol/L, HDL-C: (0.88±0.30) mmol/L, (1.32±0.39) mmol/L, (1.24±0.35) mmol/L. The effect of lowering blood lipid in group C was the worst (1 month 30%; 3 months 16.7%), in group D was the best (1 month 76.6%; 3 months 70%). There was rebound phenomenon of HDL-C level in group D as time changed [HDL-C: before treatment (0.88±0.30) mmol/L, 1 month (1.32±0.39) mmol/L, 3 months (0.97±0.36) mmol/L]. The Lactobacillus and Bifidobacteria in group C at 1 month after treatment was significantly higher than before treatment and three months after treatment [(7.49±0.34) vs (6.85±0.26), (6.73±0.28); (9.50±0.15) vs (9.32±0.12), (9.22±0.14)], and Lactobacillus and Bifidobacteria in group D at 1 month and 3 months after treatment was significantly higher than before treatment [(7.63±0.62), (7.42±0.59) vs (6.88±0.23); (9.55±0.14), (9.51±0.11) vs (9.27±0.13)]. Conclusion Lactobacillus and Bifidobacterium intervention treatment has positive therapeutic effect in patients with hyperlipidemia.

关键词

肠道菌群/高脂血症/降血脂治疗

Key words

intestinal microflora/hyperlipidemia/lipid-lowering therapy

分类

医药卫生

引用本文复制引用

闫志辉,崔立红,王晓辉,贺星,李超,弓三东,罗哲,季梦辰..乳酸杆菌与双歧杆菌对高脂血症治疗的相关性研究[J].解放军医学院学报,2015,(10):983-986,1010,5.

基金项目

海军后勤科研计划课题(CHJ12J027)Supported by the Foundation of Logistics of Chinese Navy(CHJ12J027) (CHJ12J027)

解放军医学院学报

OACSTPCD

2095-5227

访问量0
|
下载量0
段落导航相关论文